Literature DB >> 21165401

Squamous cell carcinoma of the esophagus: evaluation of the status of epidermal growth factor receptors (EGFR and HER-2) by immunohistochemistry and in situ hybridization.

V V Delektorskaya1, G Yu Chemeris, L E Zavalishina, A A Ryazantseva, A Yu Grigorchuk, P V Kononets, M I Davydov.   

Abstract

We performed a parallel evaluation of the status of epidermal growth factor receptors EGFR and HER-2 in tumor samples from 31 patients with squamous cell carcinoma of the esophagus. Hyperexpression of proteins was detected by immunohistochemical methods and gene amplification and other chromosome abnormalities were studied using FISH reaction. Evaluation of EGFR status showed that amplification of EGFR gene was present in 25% cases and chromosome 7 polysomy was detected in 29.2% cases positive by protein expression (2+/3+). Immunohistochemically positive EGFR status was confirmed by the results of FISH reaction for gene amplification and chromosome 7 polysomy in 54.2% cases (p=0.002). During evaluation of HER-2 status in the tumor, hyperexpression of the protein detected histochemically was not confirmed by FISH reaction for detection of amplification of the corresponding gene in 16.1% cases. In 22.6% patients, chromosome 7 polysomy was detected; it was not accompanied by amplification of HER-2 gene, but was related to immunohistochemically positive status of the tumor. Hyperexpression of EGFR protein significantly correlated with the presence of intravascular invasion (p=0.006) and increased depth of invasion (p=0.044), while amplification of EGFR gene (≥2.2) correlated with low differentiation degree of the tumor (p=0.006). The outcome of the disease was not associated with EGFR status at the gene and protein levels, whereas clinical course of the disease in patients with immunohistochemically negative expression of HER-2 protein was more favorable than in patients with positive expression (p=0.004). The results of this study suggest that hyperexpression/amplification of EGFR and hyperexpression of HER-2 are important clinical markers for evaluation of disease prognosis and development of new regimens of targeted therapy for patients with squamous cells carcinoma of the esophagus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165401     DOI: 10.1007/s10517-010-1007-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

1.  C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.

Authors:  Ya-Ping Xu; Gang Lin; Xiao-Jiang Sun; Mao-Hui Yan; Gu Zhang; Jin-Lin Hu; Wen-Yong Sun; Jin-Ming Yu
Journal:  J Cancer       Date:  2016-03-18       Impact factor: 4.207

2.  Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.

Authors:  Gang Lin; Xiao-Jiang Sun; Qian-Bo Han; Zhun Wang; Ya-Ping Xu; Jia-Lei Gu; Wei Wu; G U Zhang; Jin-Lin Hu; Wen-Yong Sun; Wei-Min Mao
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

3.  Molecular pathological diagnosis for early esophageal cancer in Kazakh patients.

Authors:  Idiris Awut; Madiniyet Niyaz; Hadeti Biekemitoufu; Zhu Zhang; Ilyar Sheyhedin; Wen Hao
Journal:  Oncol Lett       Date:  2011-12-30       Impact factor: 2.967

4.  Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia.

Authors:  Behnoush Abedi-Ardekani; Nazir Ahmad Dar; Mohammad Muzaffar Mir; Showkat Ahmad Zargar; M Muqbool Lone; Ghyslaine Martel-Planche; Stéphanie Villar; Mounia Mounawar; Farrokh Saidi; Reza Malekzadeh; Pierre Hainaut
Journal:  BMC Cancer       Date:  2012-12-17       Impact factor: 4.430

5.  Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.

Authors:  Zhenhua Gao; Xue Meng; Dianbin Mu; Xindong Sun; Jinming Yu
Journal:  Oncol Lett       Date:  2014-02-13       Impact factor: 2.967

6.  The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis.

Authors:  Xiao-wei Wang; Xin-hui Shi; Yu-suo Tong; Xiu-feng Cao
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.